|
NACC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.119600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.383400E-03 |
| Normal-vs-Stage2 |
5.864800E-03 |
| Normal-vs-Stage3 |
2.813200E-01 |
| Normal-vs-Stage4 |
4.046000E-01 |
| Stage1-vs-Stage2 |
2.081400E-01 |
| Stage1-vs-Stage3 |
1.884230E-01 |
| Stage1-vs-Stage4 |
2.123800E-02 |
| Stage2-vs-Stage3 |
6.652000E-02 |
| Stage2-vs-Stage4 |
7.478200E-03 |
| Stage3-vs-Stage4 |
1.440380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.797800E-03 |
| Normal-vs-AfricanAmerican |
1.347810E-01 |
| Normal-vs-Asian |
5.903400E-01 |
| Caucasian-vs-AfricanAmerican |
1.438670E-03 |
| Caucasian-vs-Asian |
2.260800E-01 |
| AfricanAmerican-vs-Asian |
9.551200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.515500E-03 |
| Normal-vs-Female |
8.544400E-01 |
| Male-vs-Female |
1.236420E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.730200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.288200E-02 |
| Normal-vs-Age(61-80Yrs) |
5.947900E-02 |
| Normal-vs-Age(81-100Yrs) |
5.022600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.286600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.116800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.213200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.283200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.630200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.676200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.772400E-01 |
| Normal-vs-Grade 2 |
1.86231000000037E-05 |
| Normal-vs-Grade 3 |
2.519600E-02 |
| Normal-vs-Grade 4 |
4.241000E-03 |
| Grade 1-vs-Grade 2 |
1.056170E-01 |
| Grade 1-vs-Grade 3 |
1.700550E-01 |
| Grade 1-vs-Grade 4 |
3.272400E-01 |
| Grade 2-vs-Grade 3 |
2.584300E-02 |
| Grade 2-vs-Grade 4 |
5.25849999988282E-07 |
| Grade 3-vs-Grade 4 |
6.45559999999934E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.30269994791377E-09 |
| Normal-vs-ccB subtype |
5.975400E-01 |
| ccA subtype-vs-ccB subtype |
6.90430046468293E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.960500E-03 |
| Normal-vs-N1 |
6.040400E-03 |
| N0-vs-N1 |
1.097890E-03 |
|
|
